Buscador de publicaciones

Publicaciones

  • Domingo P, Gutierrez Mdel M, Gallego-Escuredo JM, Torres F, Mateo MG, Villarroya-Terrade J, Lamarca K, Domingo JC, Vidal F, Villarroya-Gombau F and Giralt M.

    A 48-week study of fat molecular alterations in HIV naive patients starting tenofovir/emtricitabine with lopinavir/ritonavir or efavirenz.

    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES . 66(5): 457-465. Nº de citas: 13

    [doi:10.1097/QAI.0000000000000205]

  • Hondares E, Gallego-Escuredo JM, Flachs P, Frontini A, Cereijo R, Goday A, Perugini J, Kopecky P, Giralt M, Cinti S, Kopecky J and Villarroya-Gombau F.

    Fibroblast growth factor-21 is expressed in neonatal and pheochromocytoma-induced adult human brown adipose tissue.

    METABOLISM-CLINICAL AND EXPERIMENTAL . 63(3): 312-317. Nº de citas: 73

    [doi:10.1016/j.metabol.2013.11.014]

  • Gallego-Escuredo JM, Villarroya-Terrade J, Domingo P, Targarona EM, Alegre M, Domingo JC, Villarroya-Gombau F and Giralt M.

    Differentially altered molecular signature of visceral adipose tissue in HIV-1-associated lipodystrophy.

    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES . 64(2): 142-148. Nº de citas: 27

    [doi:10.1097/QAI.0b013e31829bdb67]

  • Palomer FX, Capdevila-Busquets E, Alvarez-Guardia D, Barroso E, Pallàs M, Camins A, Davidson MM, Planavila A, Villarroya-Gombau F and Vazquez M.

    Resveratrol induces nuclear factor-?B activity in human cardiac cells.

    INTERNATIONAL JOURNAL OF CARDIOLOGY . 167(6): 2507-2516. Nº de citas: 31

    [doi:10.1016/j.ijcard.2012.06.006]

  • Villarroya-Gombau F and Vidal-Puig A.

    Beyond the sympathetic tone: the new brown fat activators.

    CELL METABOLISM . 17(5): 638-643. Nº de citas: 173

    [doi:10.1016/j.cmet.2013.02.020]

  • Gallego-Escuredo JM, Domingo P, Fontdevila J, Villarroya-Terrade J, Domingo JC, Martinez E, Giralt M and Villarroya-Gombau F.

    Hypertrophied facial fat in an HIV-1-infected patient after autologous transplantation from 'buffalo hump' retains a partial brown-fat-like molecular signature.

    ANTIVIRAL THERAPY . 18(4): 635-639. Nº de citas: 3

    [doi:10.3851/IMP2528]

  • Planavila A, Dominguez E, Navarro M, Vinciguerra M, Iglesias R, Giralt M, Lope-Piedrafita S, Ruberte J and Villarroya-Gombau F.

    Dilated cardiomyopathy and mitochondrial dysfunction in Sirt1-deficient mice: a role for Sirt1-Mef2 in adult heart.

    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY . 53(4): 521-531. Nº de citas: 76

    [doi:10.1016/j.yjmcc.2012.07.019]

  • Díaz-Delfín J, Domingo P, Mateo MG, Gutierrez Mdel M, Domingo JC, Giralt M and Villarroya-Gombau F.

    Effects of rilpivirine on human adipocyte differentiation, gene expression, and release of adipokines and cytokines.

    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY . 56(6): 3369-3375. Nº de citas: 28

    [doi:10.1128/AAC.00104-12]

  • Armengol J, Villena JA, Hondares E, Carmona MC, Sul HS, Iglesias R, Giralt M and Villarroya-Gombau F.

    Pref-1 in brown adipose tissue: specific involvement in brown adipocyte differentiation and regulatory role of C/EBPd.

    BIOCHEMICAL JOURNAL . 443(3): 799-810. Nº de citas: 22

    [doi:10.1042/BJ20111714]

  • Díaz-Delfín J, Domingo P, Wabitsch M, Giralt M and Villarroya-Gombau F.

    HIV-1 Tat protein impairs adipogenesis and induces the expression and secretion of proinflammatory cytokines in human SGBS adipocytes.

    ANTIVIRAL THERAPY . 17(3): 529-540. Nº de citas: 31

    [doi:10.3851/IMP2021]